Scientists use immune cells to smuggle molecules across the blood-brain barrier in the hopes of treating neurodegenerative diseases.
Biotech startup Greenlight Biosciences has a cell-free approach to microbial chemical production.
A method for single-cell DNA analysis could provide a safer genetic screen for IVF.
Despite promising results in controlling neuronal activity, leaders in brain research still wrestle over turning their work into treatments.
By delivering gene therapies to patients before they go blind, doctors may be able to prevent the loss of many important light-detecting cells.
Notre Dame researchers will test a concussion-detection app on nearly a thousand high school and youth football players.
New research indicates that chemical fingerprints can make positive matches between batches of sarin.
Several gene therapies are or will soon be in late-stage human trials. One of them could be the first to get FDA approval for sale in the U.S.
Researchers are using smart helmets and imaging to study brain injury risk in young football players over a season.
By studying the interactions between our bodies and our microbes, a startup hopes to find new ways of treating disease.